Multifunctionality of PAI-1 in fibrogenesis:: Evidence from obstructive nephropathy in PAI-1-overexpressing mice

被引:117
作者
Matsuo, S
López-Guisa, JM
Cai, XH
Okamura, DM
Alpers, CE
Bumgarner, RE
Peters, MA
Zhang, GQ
Eddy, AA
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Childrens Hosp & Reg Med Ctr, Seattle, WA 98105 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
关键词
interstitial fibrosis; plasminogen activator inhibitor-1; macrophage; urokinase; unilateral ureteral obstruction;
D O I
10.1111/j.1523-1755.2005.00327.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Plasminogen activator inhibitor-1 (PAI-1) has been implicated in the pathogenesis of chronic kidney disease based on its up-regulated expression and on the beneficial effects of PAI-1 inhibition or depletion in experimental models. PAI-1 is a multifunctional protein and the mechanisms that account for its profibrotic effects have not been fully elucidated. Methods. The present study was designed to investigate PAI-1-dependent fibrogenic pathways by comparing the unilateral ureteral obstruction model (UUO) (days 3, 7, and 14) in PAI-I-overexpressing mice (PAI-1 tg) to wild-type mice, both on a C57BL6 background. Results. Following UUO, total kidney PAI-1 mRNA and/or protein levels were significantly higher in the PAI-1 tg mice (N = 6 to 8/group) and fibrosis severity was significantly worse (days 3, 7, and 14), measured both as Sirius red-positive interstitial area (e.g., 10 +/- 3.2% vs. 4.5 +/- 1.0%) (day 14) and total kidney collagen (e.g., 11.1 +/- 1.7 vs. 6.2 +/- 1.3 mu g/mg) (day 14). By day 14, the expression of two normal tubular proteins, E-cadherin and Ksp-cadherin, were significantly lower in the PAI-1 tg mice (3.2 +/- 0.5% vs. 11.7 +/- 5.9% and 2.6 +/- 1.6) vs. 6.2 +/- 0.8%, respectively), implying more extensive tubular damage. At least four fibrogenic pathways were differentially expressed in the PAI-1 tg mice. First, interstitial macrophage recruitment was more intense (P < 0.05 days 3 and 14). Second, interstitial myofibroblast density was greater (P < 0.05 days 3 and 7) despite similar numbers of proliferating tubulointerstitial cells. Third, transforming growth factor-beta 1 (TGF-beta 1) and collagen I mRNA were significantly higher. Finally, urokinase activity was significantly lower (P < 0.05 days 7 and 14) despite similar mRNA levels. Gene microarray studies documented that that the deletion of this single profibrotic gene had far-reaching consequences on renal cellular responses to chronic injury. Conclusion. These data provide further evidence that PAI-1 is directly involved in interstitial fibrosis and tubular damage via two primary overlapping mechanisms: early effects on interstitial cell recruitment and late effects associated with decreased urokinase activity.
引用
收藏
页码:2221 / 2238
页数:18
相关论文
共 52 条
[1]   Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties [J].
Al-Fakhri, N ;
Chavakis, T ;
Schmidt-Wöll, T ;
Huang, B ;
Cherian, SM ;
Bobryshev, YV ;
Lord, RSA ;
Katz, N ;
Preissner, KT .
BIOLOGICAL CHEMISTRY, 2003, 384 (03) :423-435
[2]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[3]   uPAR: A versatile signalling orchestrator [J].
Blasi, F ;
Carmeliet, P .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :932-943
[4]  
Buchholz M, 2003, CANCER RES, V63, P4945
[5]   Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins [J].
Czekay, RP ;
Aertgeerts, K ;
Curriden, SA ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 2003, 160 (05) :781-791
[6]   The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1 [J].
Degryse, B ;
Neels, JG ;
Czekay, RP ;
Aertgeerts, K ;
Kamikubo, Y ;
Loskutoff, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22595-22604
[7]   The urokinase plasminogen activator system: Role in malignancy [J].
Duffy, MJ .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (01) :39-49
[8]   ACUTE TUBULOINTERSTITIAL NEPHRITIS ASSOCIATED WITH AMINONUCLEOSIDE NEPHROSIS [J].
EDDY, AA ;
MICHAEL, AF .
KIDNEY INTERNATIONAL, 1988, 33 (01) :14-23
[9]   Proteinuria and interstitial injury [J].
Eddy, AA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (02) :277-281
[10]   Plasminogen activator inhibitor-1 and the kidney [J].
Eddy, AA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 283 (02) :F209-F220